Clinical Trials: Sickle Cell Disease

Birmingham : Children's of Alabama

Evaluation of Spectra Optia RBC Exchange in Sickle Cell Patients

Birmingham : University of Alabama Hospital

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Mobile : University of South Alabama

Effects of HQK-1001 in Patients With Sickle Cell Disease

Phoenix : Phoenix Children's Hospital - Ctr for Cancer and Blood Disorders

Effects of HQK-1001 in Patients With Sickle Cell Disease

Little Rock : Hematology Oncology Services of Arkansas

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Berkeley : Alta Bates Summit Medical Center

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Oakland : Children's Hospital Oakland (CHO)

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Oakland : Children's Hospital and Research Center - Oakland

Effects of HQK-1001 in Patients With Sickle Cell Disease

Orange : Children's Hospital of Orange County Sickle Cell Disease Center

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Sacramento : University of California, Davis Medical Center

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

View More »

San Diego : Rady Children's Hopsital / UC San Diego University Hospital Sickle Cell Disease Center

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Aurora : University of Colorado

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Stamford : Hematology Oncology, P.C.

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Washington : Howard University

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Washington : Children's National Hospital

Effects of HQK-1001 in Patients With Sickle Cell Disease

Washington : Howard University Hospital

Effects of HQK-1001 in Patients With Sickle Cell Disease

Fort Lauderdale : Broward Oncology Associates, P.A.

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Miami : Miami Children's Hospital

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Miami : Innovative Medical Research

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Miami : University of Miami Miller School of Medicine

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Orlando : M.D. Anderson Cancer Center Orlando

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

View More »

St. Petersburg : All Children's Hospital

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Tampa : Central Tampa Hematology and Oncology Associates

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Tampa : St. Joseph Children's Hospital

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Augusta : Georgia Health Sciences University

Effects of HQK-1001 in Patients With Sickle Cell Disease

Augusta : Georgia Health Sciences University

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Augusta : Georgia Health Sciences University

Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

Chicago : University of Illinois at Chicago, Dept of Pediatrics

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Chicago : University of Illinois at Chicago

Effects of HQK-1001 in Patients With Sickle Cell Disease

Chicago : University of Illinois, Chicago

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Oak Lawn : Abington Hematology Oncology Associates, Inc

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Louisville : Kosair Children's Hospital

Evaluation of Spectra Optia RBC Exchange in Sickle Cell Patients

New Orleans : LSU Department of Pediatrics Children's Hospital

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

New Orleans : Tulane University School of Medicine

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Shreveport : LSU Health Sciences Center

Effects of HQK-1001 in Patients With Sickle Cell Disease

Baltimore : Johns Hopkins University Division of Hematology

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Baltimore : Johns Hopkins University

Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease

Baltimore : The Johns Hopkins School of Medicine

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Clinton : Oncology-Hematology Associates, P.A.

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Boston : Children's Hospital Boston - Harvard

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Boston : Boston Comprehensive Sickle Cell Center

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Boston : Childrens Hospital Boston

Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease

Boston : Dana-Farber Cancer Institute

Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease

Boston : Tufts Medical Center

Effects of HQK-1001 in Patients With Sickle Cell Disease

View More »

Boston : Brigham and Women's Hospital

Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease

Boston : Dana-Farber Cancer Institute

Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease

Boston : Boston Medical Center

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Detroit : Karmanos Cancer Institute

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Kalamazoo : West Michigan Cancer Center

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Jackson : University of Mississippi Medical Center

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Columbia : University of Missouri Child Health, Division of Pediatric Hematology/Oncology

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Kansas City : Children's Mercy Hospital

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Kansas City : Research Medical Center

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

St. Louis : Washington University

Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease

Newark : Newark Beth Israel Medical Center

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Bronx : The Children's Hospital at Montefiore Medical Center

Effects of HQK-1001 in Patients With Sickle Cell Disease

Bronx : Children's Hospital at Montefiore

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Brooklyn : Interfaith Medical Center-Comprehensive Sickle Cell Program

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Brooklyn : Maimonides Medical Center

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Brooklyn : New York Methodist Hospital Dept of Med/Sickle Cell Program

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

View More »

Brooklyn : New York Methodist Hospital

Effects of HQK-1001 in Patients With Sickle Cell Disease

Brooklyn : New York Methodist Hospital

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

New Hyde Park : Cohen Children's Medical Center of NY (CCMC)

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Syracuse : Center for Children's Cancer & Blood Disorders

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Chapel Hill : University of North Carolina at Chapel Hill

Effects of HQK-1001 in Patients With Sickle Cell Disease

Charlotte : Presbyterian Hospital Pediatric Sickle Cell Program

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Durham : Duke University Medical Center

Pilot Study Evaluating Safety & Efficacy of a DCBT: NiCord® & UNM CBU to SCD Patients After Myeloablative Therapy

Durham : Duke University Medical Center

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Durham : Duke University

Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo

Akron : Ohio Region VI Sickle Cell Program

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Cincinnati : Cincinnati Children's Medical Center

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Cincinnati : Cincinnati Childrens' Hospital

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Dayton : The Children's Medical Center of Dayton

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Philadelphia : The Children's Hospital of Philadelphia

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Pittsburgh : Children's Hospital of Pittsburgh

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Charleston : Medical University of SC-Pediatric Sickle Cell Center

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Columbia, : M. Francisco Gonzalez, M.D., P.A.

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Memphis : Diggs-Kraus Sickle Cell Center

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Nashville : Meharry Comprehensive Sickle Cell Center

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Nashville : Sickle Cell Disease and Hemoglobinopathy Clinic Children's Hospital at Vanderbilt

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Dallas : UT Southwestern Medical Center at Dallas

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Houston : Baylor College of Medicine-Texas Children's Hospital

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Newport News : Peninsula Cancer Institute

A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients

Richmond : Virginia Commonwealth Univeristy - Center on Health Disparities

Effects of HQK-1001 in Patients With Sickle Cell Disease

Richmond : Virginia Commonwealth University

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Milwaukee : Blood Center of Wisconsin

Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease

Milwaukee : Medical College of Wisconsin

Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease

Toronto : The Hospital for Sick Children

Effects of HQK-1001 in Patients With Sickle Cell Disease

Toronto : University Health Network Toronto General Hospital

Effects of HQK-1001 in Patients With Sickle Cell Disease

Toronto : The Hospital for Sick Children

Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis

Cairo : Abu El Reesh Pediatric University Hospital

Effects of HQK-1001 in Patients With Sickle Cell Disease

Cairo : Ain Sham University Hospital

Effects of HQK-1001 in Patients With Sickle Cell Disease

Creteil : Réanimation Médicale, Hôpital A Chenevier-H Mondor

Effect of Inhaled Nitric Oxide in Acute Chest Syndrome (INOSTA Study)

Creteil : Hôpital Henri Mondor

Safety Study of MP4CO in Adult Sickle Cell Patients

Paris : Hoipital Robert Debre

Nitric Oxide Therapy for Acute Chest Syndrome in Sickle Cell Disease Children

Beirut : Chronic Care Center

Effects of HQK-1001 in Patients With Sickle Cell Disease

Beirut : American University of Beirut Medical Center

Effects of HQK-1001 in Patients With Sickle Cell Disease

Beirut : Rafik Hariri University Hospital

Effects of HQK-1001 in Patients With Sickle Cell Disease

London : Guy's Hospital

Safety Study of MP4CO in Adult Sickle Cell Patients

London : King's College London

Safety Study of MP4CO in Adult Sickle Cell Patients